Teladoc Health, Inc.
TDOC
$8.93
-$0.22-2.40%
| Weiss Ratings | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.10 | |||
| Price History | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.00% | |||
| 30-Day Total Return | -11.50% | |||
| 60-Day Total Return | -16.46% | |||
| 90-Day Total Return | 4.20% | |||
| Year to Date Total Return | -6.20% | |||
| 1-Year Total Return | -42.09% | |||
| 2-Year Total Return | -64.77% | |||
| 3-Year Total Return | -85.95% | |||
| 5-Year Total Return | -93.31% | |||
| 52-Week High % Change | -42.63% | |||
| 52-Week Low % Change | 35.36% | |||
| Price | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $15.95 | |||
| 52-Week Low Price | $6.76 | |||
| 52-Week Low Price (Date) | Aug 28, 2024 | |||
| 52-Week High Price (Date) | Mar 11, 2024 | |||
| Valuation | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.59B | |||
| Enterprise Value | 1.88B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -5.88 | |||
| Earnings Per Share Growth | 338.55% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.62 | |||
| Price/Book (Q) | 1.06 | |||
| Enterprise Value/Revenue (TTM) | 0.73 | |||
| Price | $8.93 | |||
| Enterprise Value/EBITDA (TTM) | 59.12 | |||
| Enterprise Value/EBIT | -8.98 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 172.77M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 203 635 2002 | |||
| Address | 2 Manhattanville Road Purchase, NY 10577 | |||
| Website | www.teladochealth.com | |||
| Country | United States | |||
| Year Founded | 2002 | |||
| Profitability | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -8.12% | |||
| Profit Margin | -38.96% | |||
| Management Effectiveness | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -3.30% | |||
| Return on Equity | -- | |||
| Income Statement | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.57B | |||
| Total Revenue (TTM) | 2.57B | |||
| Revenue Per Share | $14.87 | |||
| Gross Profit (TTM) | 1.82B | |||
| EBITDA (TTM) | 31.72M | |||
| EBIT (TTM) | -208.79M | |||
| Net Income (TTM) | -1.00B | |||
| Net Income Avl. to Common (TTM) | -1.00B | |||
| Total Revenue Growth (Q YOY) | -3.03% | |||
| Earnings Growth (Q YOY) | -67.56% | |||
| EPS Diluted (TTM) | -5.88 | |||
| EPS Diluted Growth (Q YOY) | -61.03% | |||
| Balance Sheet | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.30B | |||
| Cash Per Share (Q) | $7.51 | |||
| Total Current Assets (Q) | 1.66B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.49B | |||
| Current Ratio (Q) | 1.767 | |||
| Book Value Per Share (Q) | $8.60 | |||
| Total Assets (Q) | 3.52B | |||
| Total Current Liabilities (Q) | 941.54M | |||
| Total Debt (Q) | 1.58B | |||
| Total Liabilities (Q) | 2.03B | |||
| Total Common Equity (Q) | 1.49B | |||
| Cash Flow | TDOC - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -124.05M | |||
| Cash from Financing (TTM) | 8.31M | |||
| Net Change in Cash (TTM) | 174.65M | |||
| Levered Free Cash Flow (TTM) | 229.78M | |||
| Cash from Operations (TTM) | 293.68M | |||
